Claritev Corp (CTEV) stock
Close on Nov 11, 2026Market cap $478.09MP/E –Yield –
Claritev Corp grew revenue 6.9% to $1.02B over the twelve months to Sep 30, 2026. Free cash flow was -$27.82M. At the latest close the market valued the company at $478.09M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $478.09M
- P/E ratio
- –
- Price to sales
- 0.47
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -5.82%
Fundamentals
- Revenue
- $1.02B
- Net income
- -$275.14M
- EPS, diluted
- -$16.41
- Free cash flow
- -$27.82M
- Book value per share
- -$20.42
- Diluted shares
- 17M
Trading
- Next earnings
- Q3 FY2026, expected soon
- Previous close
- $28.67
- Open
- $28.67
- Day's range
- $26.83 – $30.20
- Volume
- 437,980
- Average volume (20 days)
- 309,982
- Index membership
- Russell 2000 (since Jun 2025)
- Beta (5 years)
- 1.24
- 52-week range
- $11.50 – $61.22
- RSI (14 days)
- 61.9
- Volatility (1 year)
- 119.5%
- Relative volume
- 2.56×
- WACC
- 7.2%
On 1 of our idea list: Insiders buying the dip
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CTEV | S&P 500 | Difference | CTEV per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +14.4% | -2.4% | +16.8 pts | ||
| 3 months | -19.3% | -1.2% | −18.2 pts | ||
| Year to date | -34.0% | +12.3% | −46.3 pts | ||
| 1 year | -50.7% | +12.4% | −63.2 pts | ||
| 3 years | -49.3% | +78.8% | −128.1 pts | -20.2% | +21.4% |
| 5 years | -82.8% | +75.2% | −158.0 pts | -29.7% | +11.9% |
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Claritev filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Results
- Update
- Results
About Claritev
Services-Business Services, NEC
Claritev Corporation operates as a healthcare technology, data, and insights enterprise dedicated to enhancing affordability, transparency, and service quality across the United States medical system. The organization delivers its offerings through four main categories: Claims Intelligence Solutions, Network Solutions, Payment and Revenue Integrity Solutions, and Data and Analytics Solutions. These services focus on pre-payment and post-payment claims integrity, out-of-network pricing benchmarks, reference-based pricing, and medical cost transparency analytics. Claritev primarily serves commercial healthcare payers, including administrative services only platforms and third-party administrators, as well as self-insured employer plan sponsors and government healthcare payers.
Company profile, executives and historyClaritev stock: common questions
What is Claritev's stock price?
CTEV closed at $28.21 on Nov 11, 2026, down 1.60% on the day. Over the past 52 weeks it traded between $11.50 and $61.22.
What is Claritev's market cap?
Claritev was worth $478.09M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CTEV's P/E ratio?
Claritev lost money over the twelve months to Sep 30, 2026 (diluted EPS -$16.41), so it has no meaningful P/E ratio.
How much revenue does Claritev make?
Claritev reported revenue of $1.02B for the twelve months to Sep 30, 2026, up 6.9% from a year earlier.
Does Claritev pay a dividend?
No. Claritev has not paid a cash dividend over the last twelve months.
When does Claritev report earnings next?
Claritev's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.
How has CTEV stock performed over the past year?
Including dividends, CTEV returned -50.7% over the past year, against +12.4% for the S&P 500.
How many CTEV shares are sold short?
1M shares were sold short at the latest FINRA report, 9.12% of the float, or 2.9 days of average trading volume.
Who are Claritev's competitors?
Companies most similar to Claritev by business, industry and size include HQY, PAY, MAX, PRTH, PHR.
See a number that looks wrong?